-
公开(公告)号:US20110172139A1
公开(公告)日:2011-07-14
申请号:US12244602
申请日:2008-10-02
申请人: Tao Jiang , Roger Y. Tsien
发明人: Tao Jiang , Roger Y. Tsien
CPC分类号: A61K49/0043 , A61K47/65 , A61K49/0056
摘要: A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. Cleavage of X allows separation of A from B, unmasking the normal ability of the basic amino acids in B to drag cargo C into cells near the cleavage event. X is cleaved extracellularly, preferably under physiological conditions. D-amino acids are preferred for the A and B portions, to minimize immunogenicity and nonspecific cleavage by background peptidases or proteases.
摘要翻译: 本发明的肽的一般结构包括A-X-B-C,其中C是货物部分,B部分包括碱性氨基酸,X是可切割的接头序列,A部分包括酸性氨基酸。 完整结构不被细胞所占据; 然而,在X的细胞外裂解时,B-C部分被吸收,将货物运送到靶细胞。 货物可以是例如用于诊断成像的对比剂,化学治疗药物或用于治疗的放射线敏化剂。 X的裂解允许A与B分离,揭示B中碱性氨基酸的正常能力,将货物C拖入裂解事件附近的细胞。 X在细胞外裂解,优选在生理条件下。 对于A和B部分,D-氨基酸是优选的,以使由背景肽酶或蛋白酶的免疫原性和非特异性切割最小化。
-
公开(公告)号:US20100317097A1
公开(公告)日:2010-12-16
申请号:US12406702
申请日:2009-03-18
申请人: Roger Y. Tsien , B. Albert Griffin
发明人: Roger Y. Tsien , B. Albert Griffin
CPC分类号: C07F9/74 , C07F9/80 , G01N33/532
摘要: The present invention features biarsenical molecules. Target sequences that specifically react with the biarsenical molecules are also included. The present invention also features kits that include biarsenical molecules and target sequences. Tetraarsenical molecules are also featured in the invention.
摘要翻译: 本发明的特征在于双重分子。 还包括与二元分子特异性反应的靶序列。 本发明还包括包含二元分子和靶序列的试剂盒。 特征在于本发明的特征。
-
公开(公告)号:US07524972B2
公开(公告)日:2009-04-28
申请号:US11550275
申请日:2006-10-17
申请人: Roger Y. Tsien , B. Albert Griffin
发明人: Roger Y. Tsien , B. Albert Griffin
IPC分类号: C07D493/00 , C07H21/04
CPC分类号: C07F9/74 , C07F9/80 , G01N33/532
摘要: The present invention features biarsenical molecules. Target sequences that specifically react with the biarsenical molecules are also included. The present invention also features kits that include biarsenical molecules and target sequences. Tetraarsenical molecules are also featured in the invention.
-
公开(公告)号:US07459130B2
公开(公告)日:2008-12-02
申请号:US11067322
申请日:2005-02-25
申请人: Andrew A. Pham , Peter J. Coassin , Alec Tate Harootunian , Peter N. Pham , Harry Stylli , Roger Y. Tsien
发明人: Andrew A. Pham , Peter J. Coassin , Alec Tate Harootunian , Peter N. Pham , Harry Stylli , Roger Y. Tsien
IPC分类号: B01L3/00
CPC分类号: B01L3/5085 , B01J2219/00315 , B01J2219/00317 , B01J2219/00659 , B01J2219/00707 , B01J2219/0072 , B01L3/50855 , B01L9/523 , B01L2300/0654 , B01L2300/0829 , C12M23/12 , C40B60/14
摘要: The present invention relates to multi-well platforms, lids, caddies and any combination thereof. The multi-well platforms comprise a plurality of wells that can be of any shape and can be arranged in any ornamental pattern. The lid comprises an area corresponding to the well field. The caddy has a footprint approximately that of a standard 96-well microtiter plate. When the multi-well platform is engaged with the caddy, the wells of the well-field of the multi-well platform are preferably not obscured by the caddy when viewed from the bottom of the combination.
摘要翻译: 本发明涉及多孔平台,盖子,球童及其任何组合。 多井平台包括可以是任何形状的多个井,并且可以以任何装饰图案排列。 盖子包括对应于井场的区域。 球罐的尺寸大约是标准96孔微孔板的面积。 当多孔平台与球童接合时,当从组合的底部观察时,多孔平台的井场的井优选地不被球童遮蔽。
-
公开(公告)号:US07431915B2
公开(公告)日:2008-10-07
申请号:US10699562
申请日:2003-10-31
申请人: Tao Jiang , Roger Y. Tsien
发明人: Tao Jiang , Roger Y. Tsien
CPC分类号: A61K49/0043 , A61K47/65 , A61K49/0056
摘要: A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. Cleavage of X allows separation of A from B, unmasking the normal ability of the basic amino acids in B to drag cargo C into cells near the cleavage event. X is cleaved extracellularly, preferably under physiological conditions. D-amino acids are preferred for the A and B portions, to minimize immunogenicity and nonspecific cleavage by background peptidases or proteases.
摘要翻译: 本发明的肽的一般结构包括A-X-B-C,其中C是货物部分,B部分包括碱性氨基酸,X是可切割的接头序列,A部分包括酸性氨基酸。 完整结构不被细胞所占据; 然而,在X的细胞外裂解时,B-C部分被吸收,将货物运送到靶细胞。 货物可以是例如用于诊断成像的对比剂,化学治疗药物或用于治疗的放射线敏化剂。 X的裂解允许A与B分离,揭示B中碱性氨基酸的正常能力,将货物C拖入裂解事件附近的细胞。 X在细胞外裂解,优选在生理条件下。 对于A和B部分,D-氨基酸是优选的,以使由背景肽酶或蛋白酶的免疫原性和非特异性切割最小化。
-
公开(公告)号:US07157575B2
公开(公告)日:2007-01-02
申请号:US10280482
申请日:2002-10-24
申请人: Roger Y. Tsien , Gregor Zlokarnik
发明人: Roger Y. Tsien , Gregor Zlokarnik
IPC分类号: C07D501/14
CPC分类号: C07D501/36 , C07D501/00 , C07D505/00 , C07D519/00 , C12N9/86 , C12N15/85 , C12N2800/90 , C12N2830/002 , C12P17/184 , C12P17/188 , C12P35/00 , C12Q1/18 , C12Q1/34 , C12Q1/6897 , C12Q2334/00 , G01N2333/986 , G01N2415/00 , Y10S435/805
摘要: Substrates for β-lactamase of the general formula I in which one of X and Y is a fluorescent donor moiety and the other is a quencher (which may or may not re-emit); R′ is selected from the group consisting of H, lower (i.e., alkyl of 1 to about 5 carbon atoms) and (CH2)nOH, in which n is 0 or an integer from 1 to 5; R″ is selected from the group consisting of H, physiologically acceptable metal and ammonium cations, —CHR2OCO(CH2)nCH3, —CHR2OCOC(CH3)3, acylthiomethyl, acyloxy-alpha-benzyl, delta-butyrolactonyl, methoxycarbonyloxymethyl, phenyl, methylsulphinylmethyl, beta-morpholinoethyl, dialkylaminoethyl, acyloxyalkyl, dialkylaminocarbonyloxymethyl and aliphatic, in which R2 is selected from the group consisting of H and lower alkyl; A is selected from the group consisting of S, O, SO, SO2 and CH2; and Z′ and Z″ are linkers for the fluorescent donor and quencher moieties. Methods of assaying β-lactamase activity and monitoring expression in systems using β-lactamase as a reporter gene also are disclosed.
摘要翻译: 通式I的β-内酰胺酶底物,其中X和Y中的一个是荧光供体部分,另一个是猝灭剂(其可以或不再发射); R'选自H,低级(即1至约5个碳原子的烷基)和(CH 2 CH 2)n OH,其中n是 0或1〜5的整数; R“选自H,生理学上可接受的金属和铵阳离子,-CHR 2 OCO(CH 2)n CH 酰基硫基甲基,酰氧基-α-苄基,三氟甲磺酸酯,三氟甲磺酸酯, 丁基内酰胺,甲氧基羰氧基甲基,苯基,甲基亚磺酰基甲基,β-吗啉代乙基,二烷基氨基乙基,酰氧基烷基,二烷基氨基羰氧基甲基和脂族基,其中R 2选自H和低级烷基; A选自S,O,SO,SO 2和CH 2; Z'和Z“是荧光供体和猝灭剂部分的接头。 公开了使用β-内酰胺酶作为报道基因的体内测定β-内酰胺酶活性和监测表达的方法。
-
公开(公告)号:US07142290B2
公开(公告)日:2006-11-28
申请号:US11355396
申请日:2006-02-15
IPC分类号: G01N21/00
CPC分类号: G01N21/6452 , G01N21/253 , G01N33/48728 , G01N2021/6421 , G01N2021/6471 , G01N2021/6478 , G01N2021/6484 , G01N2201/0639
摘要: The invention provides for a detector assembly, fiber assembly and screening system for optical measurements.
-
公开(公告)号:US07115401B2
公开(公告)日:2006-10-03
申请号:US10334589
申请日:2002-12-31
CPC分类号: G01N33/5076 , C07D209/08 , C07D239/60 , C07D239/62 , C07D239/66 , C07D311/16 , C07F5/003 , C07F5/02 , C07F5/027 , C07F9/10 , C07F9/5728 , C09B23/02 , G01N33/5005 , G01N33/5008 , G01N33/502 , G01N33/5044 , G01N33/5058 , G01N33/5061 , G01N33/52 , G01N33/542 , G01N33/582 , G01N33/6872 , G01N2500/10 , Y10S436/80 , Y10S436/805
摘要: Methods and compositions are provided for determining the potential of a membrane. In one aspect, the method comprises: (a) introducing a first reagent comprising a hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the potential of the membrane, as described by the Nernst equation, (b) introducing a second reagent which labels the first face or the second face of the membrane, which second reagent comprises a chromophore capable of undergoing energy transfer by either (i) donating excited state energy to the fluorescent ion, or (ii) accepting excited state energy from the fluorescent ion, (c) exposing the membrane to radiation; (d) measuring energy transfer between the fluorescent ion and the second reagent, and (e) relating the energy transfer to the membrane potential. Energy transfer is typically measured by fluorescence resonance energy transfer. In some embodiments the first and second reagents are bound together by a suitable linker.In one aspect the method is used to identify compounds which modulate membrane potentials in biological membranes.
-
公开(公告)号:US07060869B2
公开(公告)日:2006-06-13
申请号:US09554000
申请日:2000-04-20
申请人: Roger Y. Tsien , Atsushi Miyawaki
发明人: Roger Y. Tsien , Atsushi Miyawaki
IPC分类号: A61K67/027
CPC分类号: C07K14/43595 , A01K2217/05 , C07K2319/00 , G01N33/542
摘要: Fluorescent indicators including a binding protein moiety, a donor fluorescent protein moiety, and an acceptor fluorescent protein moiety are described. The binding protein moiety has an analyte-binding region which binds an analyte and causes the indicator to change conformation upon exposure to the analyte. The donor moiety and the acceptor moiety change position relative to each other when the analyte binds to the analyte-binding region. The donor moiety and the acceptor moiety exhibit fluorescence resonance energy transfer when the donor moiety is excited and the distance between the donor moiety and the acceptor moiety is small. The indicators can be used to measure analyte concentrations in samples, such as calcium ion concentrations in cells.
-
公开(公告)号:US06900304B2
公开(公告)日:2005-05-31
申请号:US09865291
申请日:2001-05-24
申请人: Roger Y. Tsien , Alice Y. Ting , Jin Zhang
发明人: Roger Y. Tsien , Alice Y. Ting , Jin Zhang
IPC分类号: G01N21/78 , C07K14/435 , C07K19/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/00 , C12N15/09 , C12N15/12 , C12Q1/37 , C12Q1/42 , C12Q1/48 , G01N33/542 , C07H21/04 , C12N15/62
CPC分类号: C07K14/43595 , C07K2319/00 , C12Q1/37 , C12Q1/42 , C12Q1/485 , G01N33/542 , G01N2333/43595
摘要: A chimeric phosphorylation indicator is provided. A chimeric phosphorylation indicator can contain a donor molecule, a phosphorylatable domain, a phosphoaminoacid binding domain (PAABD), and an acceptor molecule. A chimeric phosphorylation indicator also can contain a phosphorylatable polypeptide and a fluorescent protein, wherein the phosphorylatable polypeptide is contained within the sequence of the fluorescent protein, or wherein the fluorescent protein is contained within the sequence of the phosphorylatable polypeptide. Also provided are polynucleotides encoding such chimeric phosphorylation indicators, as well as kits containing the indicators or the polynucleotides. In addition, a method of using the chimeric phosphorylation indicators to detect a kinase or phosphatase in a sample is provided.
摘要翻译: 提供嵌合磷酸化指示剂。 嵌合磷酸化指示剂可以含有供体分子,可磷酸化结构域,磷酸氨基酸结合结构域(PAABD)和受体分子。 嵌合磷酸化指示剂还可含有可磷酸化多肽和荧光蛋白,其中可磷酸化多肽包含在荧光蛋白的序列内,或其中荧光蛋白包含在可磷酸化多肽的序列内。 还提供了编码这种嵌合磷酸化指示剂的多核苷酸,以及含有指示剂或多核苷酸的试剂盒。 此外,提供了使用嵌合磷酸化指示剂来检测样品中的激酶或磷酸酶的方法。
-
-
-
-
-
-
-
-
-